How much is the latest price of dasatinib (Startax) in 2024?

Dasatinib (Dasatinib) is a drug used to treat leukemia and other cancers. It is a type of tyrosine kinase inhibitor (TKI). It is an oral drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).

Dasatinib (Dasatinib) is now on the market in China and has been included in the medical insurance system. Patients can purchase it directly in China, with the price ranging from RMB 4,000 to RMB 5,000. For specific drug pricing and medical insurance reimbursement ratios, patients are asked to go to the pharmacy of their local hospital for detailed consultation. In addition, the price of foreign generic drugs of Dasatinib (Startase) is relatively more affordable, usually only a few hundred yuan, which has a significant price advantage compared with domestic drugs. It is worth noting that the ingredients of original drugs marketed in China and foreign generic drugs are highly consistent. Therefore, when patients choose drugs, they can make reasonable choices based on their actual situation and economic conditions.

Dasatinib works by blocking tyrosine kinases in cancer cells, thereby preventing them from growing and dividing. Its mechanism of action is to inhibit the proliferation of leukemia cells by targeting and destroying the abnormal BCR-ABL fusion protein. In addition to BCR-ABL, dasatinib (Startase) also inhibits a variety of other kinases, including tumor-associated kinases such as SRCfamily kinases, c-KIT and EPHA family kinases, and thus also show potential in the treatment of other types of cancer.

For patients with CML, dasatinib (Startase) is often used as first-line treatment. In some cases, it is also used as an alternative during the treatment of patients with CML, particularly those who are resistant to or intolerant of other TKI drugs, such as imatinib. In the treatment of acute lymphoblastic leukemia (ALL), dasatinib (Startase) is often given in combination with other chemotherapy drugs.

AlthoughDasatinib is generally a relatively safe drug, but there are still some possible side effects. Common side effects include nausea, vomiting, diarrhea, fatigue, headache, and edema. In addition, dasatinib may cause serious side effects, such as heart problems, bleeding, liver problems, and lung problems. Therefore, doctors will usually monitor patients closely while taking dasatinib (Startase) and adjust the dose or pause treatment as needed.